Medicinal chemistry: controlling signals and chemical tools
Which chemical designs clarify target signaling, payload release and ligand discovery?
Five specialists select new research papers. Rowan separately reports important news across the field. Each topic can include up to five significant papers per day, and the news digest up to five significant stories.
We publish when there is something worth reading. Dates show when each update was prepared. Our weekly editions bring the deeper reporting and analysis.
Which chemical designs clarify target signaling, payload release and ligand discovery?
Which chemical-design changes improve target selectivity, local exposure and measured engagement?
Which new compound-design and assay methods connect molecular changes with measurable binding or cellular performance?
Which new compound-design studies connect molecular changes with measured target engagement and useful exposure?
Which new design approaches connect chemical changes with measured activity and developability?
Which chemical changes improve target engagement, resistance reversal and exposure?
How do INCB127443, DF142, an allosteric SHP2 scaffold, spirocyclic FAPI tracers and a BET series connect chemical substitutions to target engagement and biological performance?
Which modelling studies offer useful selectivity and lead-design hypotheses, and what do they establish?
Which measured optimisation results and comparative checks improve medicinal-chemistry decisions?
Random molecular changes put potency gains and AI ADMET predictions in experimental context.
A computational CDK2 study tests prioritisation by selectivity as well as potency.
Inductive Bio launches an assistant for assay checks and medicinal-chemistry analysis; its reported benchmark remains company-run.